R&D Senior Manager, Cell Biology, Thermo Fisher Scientific
BIOGRAPHY
Speakers
-
Jason Potter, PhD
R&D Director, Genome Editing, Thermo Fisher ScientificBIOGRAPHY
Event Date & Time
Date: October 6, 2022
Time: 9:30am IST, 12:00pm SGT, 1:00pm JST, KST, 3:00pm AEST, 5:00 NZST
Abstract
Genome editing is—or will soon be—in the clinic for several diseases and more applications are currently under development. The rapid pace of the field, spurred by the transformative CRISPR technology, demands constant updates to our scientific and technical skillsets to stay relevant.
Gibco Galaxy Tour Webinar connects you to our Gibco experts who will discuss the use of genome editing for development of next generation disease models and novel therapies. To help you take your research to the next level, we will provide an overview of how to design a genome editing experiment, share applications in stem cell disease models and discuss important considerations, such as off-target effects and GMP-grade reagents, when developing therapeutics with gene edits.
Topics include:
- Current approaches on genome editing in induced pluripotent stem cells (iPSC)
- Application of genome editing in the generation of cardiac disease models
- Design of genome editing experiment
- Application of GMP-manufactured Cas9 in primary T-cell workflow
- Minimizing off target risks with high fidelity Cas9 protein
Learning Objectives:
- You will be learning or revisiting new tools and techniques to design a genome editing experiment with iPSC for disease model generation
- You will also learn about the need for GMP-grade reagents, high-fidelity Cas9 protein and integrated genome editing workflow solutions to facilitate clinical and commercial scale manufacturing of T cells therapeutics
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
MAR 26, 2024 | 11:00 AM
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...
DEC 07, 2023 | 8:00 AM
As the vast landscape of genetic oncology continues to expand, the ability to understand and utilize the full potential of this rich data becomes increasingly challenging. As a result, resea...
FEB 08, 2024 | 10:00 AM
High-content screening (HCS) is an imaging-based, multi-parametric strategy used in drug development that generates rich datasets through multiplexing strategically chosen fluorescent dyes a...
MAR 26, 2024 | 7:00 PM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
MAR 26, 2024 | 8:00 AM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
DEC 05, 2023 | 8:00 AM
CGX10 Cell Isolation System: Introduction, Utility, and Assessment in a GMP-grade Environment for Multiparametric Cell Sorting A future of long-term, minimally toxic immunotherapy personaliz...
Loading Comments...
Finish Registering
-
APR 30, 2024Immuno-Oncology Virtual Event Series 2024
-
MAY 07, 20243rd International Biosecurity Virtual Symposium
-
JUN 06, 2024The Future of Scientific Conferencing
- See More
-
APR 24, 2024
- See More
